BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10775535)

  • 1. Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study.
    Janssen JC; Hall M; Fox NC; Harvey RJ; Beck J; Dickinson A; Campbell T; Collinge J; Lantos PL; Cipolotti L; Stevens JM; Rossor MN
    Brain; 2000 May; 123 ( Pt 5)():894-907. PubMed ID: 10775535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation.
    Janssen JC; Lantos PL; Fox NC; Harvey RJ; Beck J; Dickinson A; Campbell TA; Collinge J; Hanger DP; Cipolotti L; Stevens JM; Rossor MN
    Arch Neurol; 2001 Jun; 58(6):953-8. PubMed ID: 11405810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease.
    Heckmann JM; Low WC; de Villiers C; Rutherfoord S; Vorster A; Rao H; Morris CM; Ramesar RS; Kalaria RN
    Brain; 2004 Jan; 127(Pt 1):133-42. PubMed ID: 14570818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease.
    Sodeyama N; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H; Yamada M
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):548-51. PubMed ID: 9576554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor.
    Fox NC; Kennedy AM; Harvey RJ; Lantos PL; Roques PK; Collinge J; Hardy J; Hutton M; Stevens JM; Warrington EK; Rossor MN
    Brain; 1997 Mar; 120 ( Pt 3)():491-501. PubMed ID: 9126060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multigenerational pedigree of late-onset Alzheimer's disease implies new genetic causes.
    Jimenez-Escrig A; Gomez-Tortosa E; Baron M; Rabano A; Arcos-Burgos M; Palacios LG; Yusta A; Anta P; Perez I; Hierro M; Munoz DG; Barquero S
    Brain; 2005 Jul; 128(Pt 7):1707-15. PubMed ID: 15843424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation.
    Singleton AB; Hall R; Ballard CG; Perry RH; Xuereb JH; Rubinsztein DC; Tysoe C; Matthews P; Cordell B; Kumar-Singh S; De Jonghe C; Cruts M; van Broeckhoven C; Morris CM
    Brain; 2000 Dec; 123 Pt 12():2467-74. PubMed ID: 11099448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141I).
    Nochlin D; Bird TD; Nemens EJ; Ball MJ; Sumi SM
    Ann Neurol; 1998 Jan; 43(1):131-5. PubMed ID: 9450781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene.
    Harvey RJ; Ellison D; Hardy J; Hutton M; Roques PK; Collinge J; Fox NC; Rossor MN
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):44-9. PubMed ID: 9436726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.
    Crook R; Verkkoniemi A; Perez-Tur J; Mehta N; Baker M; Houlden H; Farrer M; Hutton M; Lincoln S; Hardy J; Gwinn K; Somer M; Paetau A; Kalimo H; Ylikoski R; Pöyhönen M; Kucera S; Haltia M
    Nat Med; 1998 Apr; 4(4):452-5. PubMed ID: 9546792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.
    Vélez JI; Lopera F; Sepulveda-Falla D; Patel HR; Johar AS; Chuah A; Tobón C; Rivera D; Villegas A; Cai Y; Peng K; Arkell R; Castellanos FX; Andrews SJ; Silva Lara MF; Creagh PK; Easteal S; de Leon J; Wong ML; Licinio J; Mastronardi CA; Arcos-Burgos M
    Mol Psychiatry; 2016 Jul; 21(7):916-24. PubMed ID: 26619808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease.
    Yasuda M; Hirono N; Maeda K; Imamura T; Mori E; Tanaka C
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):722-6. PubMed ID: 10329743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease.
    Bertoli Avella AM; Marcheco Teruel B; Llibre Rodriguez JJ; Gomez Viera N; Borrajero Martinez I; Severijnen EA; Joosse M; van Duijn CM; Heredero Baute L; Heutink P
    Neurogenetics; 2002 Oct; 4(2):97-104. PubMed ID: 12484344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.
    Lendon CL; Martinez A; Behrens IM; Kosik KS; Madrigal L; Norton J; Neuman R; Myers A; Busfield F; Wragg M; Arcos M; Arango Viana JC; Ossa J; Ruiz A; Goate AM; Lopera F
    Hum Mutat; 1997; 10(3):186-95. PubMed ID: 9298817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene.
    Marcon G; Giaccone G; Cupidi C; Balestrieri M; Beltrami CA; Finato N; Bergonzi P; Sorbi S; Bugiani O; Tagliavini F
    J Neuropathol Exp Neurol; 2004 Mar; 63(3):199-209. PubMed ID: 15055444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very early onset AD with a de novo mutation in the presenilin 1 gene (Met 233 Leu).
    Portet F; Dauvilliers Y; Campion D; Raux G; Hauw JJ; Lyon-Caen O; Camu W; Touchon J
    Neurology; 2003 Oct; 61(8):1136-7. PubMed ID: 14581682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
    Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L
    Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.